Epidemiology of stomach cancer
- PMID: 35431510
- PMCID: PMC8968487
- DOI: 10.3748/wjg.v28.i12.1187
Epidemiology of stomach cancer
Abstract
Despite a decline in incidence and mortality during the last decades, stomach cancer is one of the main health challenges worldwide. According to the GLOBOCAN 2020 estimates, stomach cancer caused approximately 800000 deaths (accounting for 7.7% of all cancer deaths), and ranks as the fourth leading cause of cancer deaths in both genders combined. About 1.1 million new cases of stomach cancer were diagnosed in 2020 (accounting for 5.6% of all cancer cases). About 75% of all new cases and all deaths from stomach cancer are reported in Asia. Stomach cancer is one of the most lethal malignant tumors, with a five-year survival rate of around 20%. There are some well-established risk factors for stomach cancer: Helicobacter pylori infection, dietary factors, tobacco, obesity, and radiation. To date, the most important way of preventing stomach cancer is reduced exposure to risk factors, as well as screening and early detection. Further research on risk factors can help identify various opportunities for more effective prevention. Screening programs for stomach cancer have been implemented in a few countries, either as a national or opportunistic screening of high-risk individuals only. Generally, due to its high aggressiveness and heterogeneity, stomach cancer still remains a severe global health problem.
Keywords: Epidemiology; Incidence; Mortality; Predictive factors; Prevention; Stomach cancer; Survival.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: No potential conflicts of interest. No financial support.
Figures




Similar articles
-
Changing Trends in Stomach Cancer Throughout the World.Curr Gastroenterol Rep. 2017 Aug;19(8):36. doi: 10.1007/s11894-017-0575-8. Curr Gastroenterol Rep. 2017. PMID: 28730504 Free PMC article. Review.
-
Epidemiology of gastric cancer and perspectives for prevention.Salud Publica Mex. 1997 Jul-Aug;39(4):318-30. doi: 10.1590/s0036-36341997000400010. Salud Publica Mex. 1997. PMID: 9337564 Review.
-
Epidemiology of gastric cancer.IARC Sci Publ. 2004;(157):311-26. IARC Sci Publ. 2004. PMID: 15055304 Review.
-
Burden of Gastric Cancer.Clin Gastroenterol Hepatol. 2020 Mar;18(3):534-542. doi: 10.1016/j.cgh.2019.07.045. Epub 2019 Jul 27. Clin Gastroenterol Hepatol. 2020. PMID: 31362118 Free PMC article. Review.
-
Twenty five years since the first prospective study by Forman et al. (1991) on Helicobacter pylori and stomach cancer risk.Cancer Epidemiol. 2016 Apr;41:159-64. doi: 10.1016/j.canep.2016.02.002. Epub 2016 Feb 26. Cancer Epidemiol. 2016. PMID: 26922171 Review.
Cited by
-
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer.World J Gastroenterol. 2023 Feb 14;29(6):997-1010. doi: 10.3748/wjg.v29.i6.997. World J Gastroenterol. 2023. PMID: 36844144 Free PMC article. Review.
-
Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma.J Transl Med. 2023 Mar 13;21(1):191. doi: 10.1186/s12967-023-04033-6. J Transl Med. 2023. PMID: 36915111 Free PMC article.
-
Perioperative chemotherapy strategies in diffuse gastric cancer.World J Gastrointest Surg. 2025 Jan 27;17(1):101326. doi: 10.4240/wjgs.v17.i1.101326. World J Gastrointest Surg. 2025. PMID: 39872775 Free PMC article.
-
The Role of Neural Network Analysis in Identifying Predictors of Gastric Cancer.Acta Inform Med. 2024;32(2):99-106. doi: 10.5455/aim.2024.32.99-106. Acta Inform Med. 2024. PMID: 39959676 Free PMC article.
-
Association study of TYMS gene expression with TYMS and ENOSF1 genetic variants in neoadjuvant chemotherapy response of gastric cancer.J Pathol Transl Med. 2025 Mar;59(2):105-114. doi: 10.4132/jptm.2024.11.05. Epub 2025 Feb 25. J Pathol Transl Med. 2025. PMID: 40195828 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin . 2021;71:209–249. - PubMed
-
- Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021:Epub ahead of print. - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2018;68:394–424. - PubMed
-
- Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol . 2019 - PMC - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin . 2016;66:7–30. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical